Celltrion | 068270 - 股本和储备

金融业

KRW

KRW 768.81B

现金及等价物

KRW 56.79B

KRW 92.83B

KRW 481.57B

KRW 292.71B

KRW 160.58B

股息收益率

0.38

KRW 13.41B

KRW 19.64B

1.07K

EPS每股收益

KRW 1.35K

股本和储备

KRW 434.82B

KRW 39.29B

债务利息支出

KRW 19B

KRW 779.01M

KRW 411.27B

KRW 38923.06B

KRW 8.82B

KRW 119.22B

KRW 12.9B

普通股股本

KRW 229.65M

58.97

KRW 11.84B

KRW 1240B

销售和管理费用

KRW 9.32B

KRW 126B

贸易债权人

KRW 88.58B

应收帐款人

KRW 2009.82B

	股本和储备	更改		日
Akebia Therapeutics	USD 25.02M		2.36M	2026-06
Alaunos Therapeutics	USD 1.29M		865K	2026-03
Avita Medical	AUD -16.65M		3.76M	2025-12
Celltrion	KRW 434.82B		1.14B	2026-03
Dianthus Therapeutics	USD 1.17B		29.29M	2026-06
Ionis Pharmaceuticals	USD 439.74M		51.68M	2026-06
IQVIA Holdings	USD 6.17B		50M	2026-06
Moderna	USD 6.76B		647M	2026-06
Organon & Co	USD 1.01B		103M	2026-06
Revvity	USD 7.18B		67.62M	2026-03
Tectonic Therapeutic	USD 230.42M		20.91M	2026-03
Viatris	USD 14.26B		397.3M	2026-06
Xeris Pharmaceuticals	USD -9.73M		22.74M	2026-06